GenFleet eyes proof of concept with $50M series B

Looking to start its first international and proof-of-concept trials, GenFleet raised more than $50 million in a series B round led by CDH and Shenzhen Capital group.

The round saw participation by new investors South China Venture Capital, Panlin Capital, Lake Capital, BOCOM International, Guoxin Sichuang (Beijing) Investment and R&G PharmaStudies and existing investors Sinopharm Capital, Lake Bleu Capital and HighLight Capital. ...